From: Single food focus dietary guidance: lessons learned from an economic analysis of egg consumption
Condition | Studies Used to Estimate Cost (Base case, Min-Max) | Studies Used to Estimate Attribution (Percent Attributed, Min-Max) |
---|---|---|
Coronary heart disease | Rosamond et al., 2007 [11] ($156.4B, $117B-$196B) | Barraj et al. 2008 [12] (0.30%, 0.10%–0.50%) |
Eye health: Age-related macular degeneration | Halpern et al., 2006 [14]; Schmier et al., 2006a [18]; Schmier et al., 2006b [19]; Salm et al., 2006 [16], 2006; Rein et al., 2006 [15]; Coleman & Yu, 2008 [39] ($10.1B, $198.8 M-$19.96B) | Seddon et al., 1994 [35]; Handelman et al., 1999 [34]; Gale et al., 2003 [36]; Chung et al., 2004 [37] (9.5%, 4%–15%) |
Eye health: Cataract | Rein et al., 2006 [15]; Schmier et al., 2007a (([21]; Schmier et al., 2007b [20] ($20.1B, $15.1B-$25.1B) | Handelman et al., 1999 [34]; Chasan-Taber et al., 1999 [32]; Vu et al., 2006 [33] (11%, 1%–21%) |
Muscle mass: Sarcopenia | Janssen et al., 2004 [26] ($25.7 M, $16.1 M-$36.3 M) | Assumption (0.50%, 0.38%–0.63%) |
Fetal health: Neural tube defects | Ouyang et al., 2007 [40]; Robbins et al., 2007 [41] ($52.0 M, $39.0 M-$64.9 M) | Shaw et al., 2004 [29]; Zeisel 2000 [38] (9%, 6.75%–11.25%) |